Skip to main content
NCBI home page
Biochemical Journal logoLink to Biochemical Journal
. 1998 Feb 1;329(Pt 3):689–698. doi: 10.1042/bj3290689

Analysis of the combined effect of two linear inhibitors on a single enzyme.

J J Martinez-Irujo 1, M L Villahermosa 1, J Mercapide 1, J F Cabodevilla 1, E Santiago 1
PMCID: PMC1219094  PMID: 9445400

Abstract

Different methods for studying the concurrent effects of two linear inhibitors on a single enzyme have been published, including the fractional product of Webb, the Yonetani-Theorell plot or the method of Chou and Talalay. Recently the use of combination plots has also been advocated for this purpose. We have evaluated the applicability of these methods and found that most of them depend on assumptions about the mechanism of action of the inhibitors. If the mechanism of action is not completely understood, or if some assumptions about the mechanism are unfounded, the parameters obtained may be meaningless. Even if these assumptions are correct, the interaction can be advantageously measured using an alternative representation that does not require a knowledge of the inhibition constants and allows experimental data to be retrieved from the plot. In other cases it is the interpretation of the results rather than the validity of the method that is misleading. A common mistake is to take the exclusivity of the effects of two inhibitors as exclusivity of their binding. We show that this assumption is seldom justified. In any case, it is possible to decide whether the combination of two or more inhibitors is more effective than their individual use by means of isobolographic analysis, even when no information about their mechanism of action is available.

Full Text

The Full Text of this article is available as a PDF (341.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Asante-Appiah E., Chan W. W. Analysis of the interactions between an enzyme and multiple inhibitors using combination plots. Biochem J. 1996 Nov 15;320(Pt 1):17–26. doi: 10.1042/bj3200017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Asante-Appiah E., Chan W. W. Synergistic binding of inhibitors to the protease from HIV type 1. Biochem J. 1996 Apr 1;315(Pt 1):113–117. doi: 10.1042/bj3150113. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Balzarini J., Pérez-Pérez M. J., San-Félix A., Camarasa M. J., Bathurst I. C., Barr P. J., De Clercq E. Kinetics of inhibition of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase by the novel HIV-1-specific nucleoside analogue [2',5'-bis-O-(tert-butyldimethylsilyl)-beta-D-ribofuranosyl]-3'-spiro-5 "- (4"-amino-1",2"-oxathiole-2",2"-dioxide)thymine (TSAO-T). J Biol Chem. 1992 Jun 15;267(17):11831–11838. [PubMed] [Google Scholar]
  4. Berenbaum M. C. Synergy, additivism and antagonism in immunosuppression. A critical review. Clin Exp Immunol. 1977 Apr;28(1):1–18. [PMC free article] [PubMed] [Google Scholar]
  5. Berenbaum M. C. What is synergy? Pharmacol Rev. 1989 Jun;41(2):93–141. [PubMed] [Google Scholar]
  6. Carroll S. S., Stahlhut M., Geib J., Olsen D. B. Inhibition of HIV-1 reverse transcriptase by a quinazolinone and comparison with inhibition by pyridinones. Differences in the rates of inhibitor binding and in synergistic inhibition with nucleoside analogs. J Biol Chem. 1994 Dec 23;269(51):32351–32357. [PubMed] [Google Scholar]
  7. Chan W. W., Pfuetzner R. A. General occurrence of binding synergism in zinc proteases and its possible significance. Eur J Biochem. 1993 Dec 1;218(2):529–534. doi: 10.1111/j.1432-1033.1993.tb18406.x. [DOI] [PubMed] [Google Scholar]
  8. Chang G. G., Huang S. M., Chiou S. H. Kinetic mechanism of the endogenous lactate dehydrogenase activity of duck epsilon-crystallin. Arch Biochem Biophys. 1991 Feb 1;284(2):285–291. doi: 10.1016/0003-9861(91)90297-v. [DOI] [PubMed] [Google Scholar]
  9. Chou T. C., Talalay P. Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv Enzyme Regul. 1984;22:27–55. doi: 10.1016/0065-2571(84)90007-4. [DOI] [PubMed] [Google Scholar]
  10. Chou T. C., Talaly P. A simple generalized equation for the analysis of multiple inhibitions of Michaelis-Menten kinetic systems. J Biol Chem. 1977 Sep 25;252(18):6438–6442. [PubMed] [Google Scholar]
  11. Cook G. A., Mynatt R. L., Kashfi K. Yonetani-Theorell analysis of hepatic carnitine palmitoyltransferase-I inhibition indicates two distinct inhibitory binding sites. J Biol Chem. 1994 Mar 25;269(12):8803–8807. [PubMed] [Google Scholar]
  12. Crans D. C., Simone C. M., Holz R. C., Que L., Jr Interaction of porcine uterine fluid purple acid phosphatase with vanadate and vanadyl cation. Biochemistry. 1992 Dec 1;31(47):11731–11739. doi: 10.1021/bi00162a009. [DOI] [PubMed] [Google Scholar]
  13. DeRuiter J., Mayfield C. A. Inhibitory activity and mechanism of inhibition of the N-[[(4-benzoylamino)phenyl]sulfonyl]amino acid aldose reductase inhibitors. Biochem Pharmacol. 1990 Nov 15;40(10):2219–2226. doi: 10.1016/0006-2952(90)90715-w. [DOI] [PubMed] [Google Scholar]
  14. DiGregorio M., Pickering D. S., Chan W. W. Multiple sites and synergism in the binding of inhibitors to microsomal aminopeptidase. Biochemistry. 1988 May 17;27(10):3613–3617. doi: 10.1021/bi00410a013. [DOI] [PubMed] [Google Scholar]
  15. Drusano G. L., Prichard M., Bilello P. A., Bilello J. A. Modeling combinations of antiretroviral agents in vitro with integration of pharmacokinetics: guidance in regimen choice for clinical trial evaluation. Antimicrob Agents Chemother. 1996 May;40(5):1143–1147. doi: 10.1128/aac.40.5.1143. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Fletcher R. S., Arion D., Borkow G., Wainberg M. A., Dmitrienko G. I., Parniak M. A. Synergistic inhibition of HIV-1 reverse transcriptase DNA polymerase activity and virus replication in vitro by combinations of carboxanilide nonnucleoside compounds. Biochemistry. 1995 Aug 15;34(32):10106–10112. doi: 10.1021/bi00032a002. [DOI] [PubMed] [Google Scholar]
  17. Garrigos M., Mir L. M., Orlowski S. Competitive and non-competitive inhibition of the multidrug-resistance-associated P-glycoprotein ATPase--further experimental evidence for a multisite model. Eur J Biochem. 1997 Mar 1;244(2):664–673. doi: 10.1111/j.1432-1033.1997.00664.x. [DOI] [PubMed] [Google Scholar]
  18. Gu Z., Quan Y., Li Z., Arts E. J., Wainberg M. A. Effects of non-nucleoside inhibitors of human immunodeficiency virus type 1 in cell-free recombinant reverse transcriptase assays. J Biol Chem. 1995 Dec 29;270(52):31046–31051. doi: 10.1074/jbc.270.52.31046. [DOI] [PubMed] [Google Scholar]
  19. Kovacic H., Gallice P., Crevat A. Inhibition of sodium pump by bepridil. An in vitro and microcalorimetric study. Biochem Pharmacol. 1992 Oct 20;44(8):1529–1534. doi: 10.1016/0006-2952(92)90468-x. [DOI] [PubMed] [Google Scholar]
  20. Martinez-Irujo J. J., Villahermosa M. L., Alberdi E., Santiago E. A checkerboard method to evaluate interactions between drugs. Biochem Pharmacol. 1996 Mar 8;51(5):635–644. doi: 10.1016/s0006-2952(95)02230-9. [DOI] [PubMed] [Google Scholar]
  21. Palatini P. The interaction between full and partial inhibitors acting on a single enzyme. A theoretical analysis. Mol Pharmacol. 1983 Jul;24(1):30–41. [PubMed] [Google Scholar]
  22. Prichard M. N., Prichard L. E., Baguley W. A., Nassiri M. R., Shipman C., Jr Three-dimensional analysis of the synergistic cytotoxicity of ganciclovir and zidovudine. Antimicrob Agents Chemother. 1991 Jun;35(6):1060–1065. doi: 10.1128/aac.35.6.1060. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Prichard M. N., Shipman C., Jr A three-dimensional model to analyze drug-drug interactions. Antiviral Res. 1990 Oct-Nov;14(4-5):181–205. doi: 10.1016/0166-3542(90)90001-n. [DOI] [PubMed] [Google Scholar]
  24. Reczkowski R. S., Ash D. E. Rat liver arginase: kinetic mechanism, alternate substrates, and inhibitors. Arch Biochem Biophys. 1994 Jul;312(1):31–37. doi: 10.1006/abbi.1994.1276. [DOI] [PubMed] [Google Scholar]
  25. Romero D. L., Busso M., Tan C. K., Reusser F., Palmer J. R., Poppe S. M., Aristoff P. A., Downey K. M., So A. G., Resnick L. Nonnucleoside reverse transcriptase inhibitors that potently and specifically block human immunodeficiency virus type 1 replication. Proc Natl Acad Sci U S A. 1991 Oct 1;88(19):8806–8810. doi: 10.1073/pnas.88.19.8806. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Scholten J. D., Zimmerman K. K., Oxender M. G., Leonard D., Sebolt-Leopold J., Gowan R., Hupe D. J. Synergy between anions and farnesyldiphosphate competitive inhibitors of farnesyl:protein transferase. J Biol Chem. 1997 Jul 18;272(29):18077–18081. doi: 10.1074/jbc.272.29.18077. [DOI] [PubMed] [Google Scholar]
  27. Strasser F., Pelton P. D., Ganzhorn A. J. Kinetic characterization of enzyme forms involved in metal ion activation and inhibition of myo-inositol monophosphatase. Biochem J. 1995 Apr 15;307(Pt 2):585–593. doi: 10.1042/bj3070585. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Tramontano E., Cheng Y. C. HIV-1 reverse transcriptase inhibition by a dipyridodiazepinone derivative: BI-RG-587. Biochem Pharmacol. 1992 Mar 17;43(6):1371–1376. doi: 10.1016/0006-2952(92)90515-k. [DOI] [PubMed] [Google Scholar]
  29. White E. L., Parker W. B., Ross L. J., Shannon W. M. Lack of synergy in the inhibition of HIV-1 reverse transcriptase by combinations of the 5'-triphosphates of various anti-HIV nucleoside analogs. Antiviral Res. 1993 Dec;22(4):295–308. doi: 10.1016/0166-3542(93)90039-l. [DOI] [PubMed] [Google Scholar]
  30. YAGI K., OZAWA T. Complex formation of apo-enzyme, co-enzyme and substrate of D-amino acid oxidase. I. Kinetic analysis using indicators. Biochim Biophys Acta. 1960 Aug 26;42:381–387. doi: 10.1016/0006-3002(60)90815-5. [DOI] [PubMed] [Google Scholar]
  31. YONETANI T., THEORELL H. STUDIES ON LIVER ALCOHOL HYDROGENASE COMPLEXES. 3. MULTIPLE INHIBITION KINETICS IN THE PRESENCE OF TWO COMPETITIVE INHIBITORS. Arch Biochem Biophys. 1964 Jul 20;106:243–251. doi: 10.1016/0003-9861(64)90184-5. [DOI] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES